Biotech Stock Finance Bio Tech

Biotech Stock News: Regeneron’s Eylea Gets An Important Approval From FDA

Good news flowed in at Regeneron Pharmaceuticals (REGN) when the FDA cleared the company’s highly successful injectable eye drug for macular edema following retinal vein occlusion (RVO), a common retinal vascular disorder. Approval for the broad RVO indication includes sub-indications like, macular edema following branch retinal vein occlusion (BRVO) and macular edema following central retinal…

Read More

Active Stock: Google (NASDAQ GOOG) Q3 Earnings Preview

Google Inc (NASDAQ GOOG) is scheduled to release and discuss its third-quarter financial result on Thursday, October 16 at 1:30 P.M. Pacific Time. Analysts at Bernstein Research believed that investors are still primarily focused on the company’s revenue growth sustainability, the trajectory of its operating expenses, margin and capex. According to Bernstein Research analysts Carlos…

Read More
Home